You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR FEBUXOSTAT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for FEBUXOSTAT

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00102440 ↗	Febuxostat Versus Allopurinol Control Trial in Subjects With Gout	Completed	Takeda	Phase 3	2002-07-01	The purpose of this study is to evaluate the safety and efficacy of febuxostat, once daily (QD), versus allopurinol in subjects with gout.
NCT00174915 ↗	Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.	Completed	Takeda	Phase 3	2003-02-01	The purpose of this study is to compare febuxostat, allopurinol and placebo, once daily (QD), in subjects with gout.
NCT00174941 ↗	Long-Term Safety of Febuxostat in Subjects With Gout.	Completed	Takeda	Phase 2	2001-03-01	The purpose of this study is to evaluate the long-term safety of febuxostat, once daily (QD), in maintaining serum urate levels within clinically acceptable levels in subjects with gout.
NCT00174967 ↗	Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout	Completed	Takeda	Phase 2	2001-01-01	The purpose of this study is to determine the efficacy of febuxostat, once daily (QD), in reducing serum urate levels in subjects with gout.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for FEBUXOSTAT

Condition Name

Chart
Table

Condition Name for FEBUXOSTAT
Intervention	Trials
Gout	36
Hyperuricemia	18
Chronic Kidney Disease	4
Hypertension	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for FEBUXOSTAT
Intervention	Trials
Gout	38
Hyperuricemia	30
Kidney Diseases	11
Renal Insufficiency, Chronic	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for FEBUXOSTAT

Trials by Country

Map
Table

Trials by Country for FEBUXOSTAT
Location	Trials
United States	448
Japan	31
China	25
Canada	19
Poland	14
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for FEBUXOSTAT
Location	Trials
Texas	22
California	20
Florida	18
Virginia	16
North Carolina	16
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for FEBUXOSTAT

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for FEBUXOSTAT
Clinical Trial Phase	Trials
Phase 4	17
Phase 3	19
Phase 2/Phase 3	1
[disabled in preview]	26
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for FEBUXOSTAT
Clinical Trial Phase	Trials
Completed	56
Not yet recruiting	8
Recruiting	8
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for FEBUXOSTAT

Sponsor Name

Chart
Table

Sponsor Name for FEBUXOSTAT
Sponsor	Trials
Takeda	19
Ardea Biosciences, Inc.	6
Jiangsu HengRui Medicine Co., Ltd.	6
[disabled in preview]	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for FEBUXOSTAT
Sponsor	Trials
Industry	65
Other	58
NIH	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.